Publications
- The WNT/beta-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro2019 | Second Faculty of Medicine
- Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinoma2024 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy2023 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Science
- Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors2022 | Second Faculty of Medicine, Central Library of Charles University
- Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy2022 | Second Faculty of Medicine
- The Role of miR-155 in Antitumor Immunity2022 | Second Faculty of Medicine
- LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy2022 | Second Faculty of Medicine
- IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions2021 | Second Faculty of Medicine, Faculty of Science
- Thapsigargin-stimulated lad2 human mast cell line is a potent cellular adjuvant for the maturation of monocyte-derived dendritic cells for adoptive cellular immunotherapy2021 | Second Faculty of Medicine
- CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein2021 | Second Faculty of Medicine
Loading network view...